rs121912637
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM2PP2PP3_StrongPP5_Very_Strong
The NM_021625.5(TRPV4):c.2396C>T(p.Pro799Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_021625.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Metatropic dysplasia Pathogenic:3
- -
- -
- -
Charcot-Marie-Tooth disease axonal type 2C Pathogenic:2
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PS3,PM1,PM2,PM5,PP3. -
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 799 of the TRPV4 protein (p.Pro799Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with metatropic and spondylometaphyseal dysplasia (PMID: 19232556, 20425821, 20503319, 20577006, 21658220). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 4998). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TRPV4 protein function. Experimental studies have shown that this missense change affects TRPV4 function (PMID: 20425821, 21573172, 26170305, 26249260). For these reasons, this variant has been classified as Pathogenic. -
Spondyloepimetaphyseal dysplasia, Maroteaux type Pathogenic:2
- -
PS3, PS4, PM1, PM2, PM5, PP3, PP5 -
not provided Pathogenic:2
- -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Published functional studies demonstrate a damaging effect as this variant increases the activity of the TRPV4 cation channel (Camacho et al., 2010; Loukin et al., 2011; Loukin et al., 2015); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 19232556, 21573172, 20577006, 20425821, 26249260, 21658220, 31808622, 33710406, 20503319, 26170305) -
Inborn genetic diseases Pathogenic:1
- -
Parastremmatic dwarfism Pathogenic:1
- -
Spondylometaphyseal dysplasia, Kozlowski type Pathogenic:1
The missense variant p.P799L in TRPV4 (NM_021625.4) has been reported previously in multiple affected indviduals with metatropic and spondylometaphyseal dyspalsia (Camacho et al,2010, Nishimura et al,2010). It is a hot spot mutation for metatropic dysplasia (Dai J et al,2010). Experimental studies have shown that this missense change results in constitutive activation of the TRPV4 protein channel (Loukin SH et al,2010; Hurd L et al, 2015). It has been submitted to ClinVar as Pathogenic.The p.P799L variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. There is a moderate physicochemical difference between proline and leucine. The p.P799L missense variant is predicted to be damaging by both SIFT and PolyPhen2. The proline residue at codon 799 of TRPV4 is conserved in all mammalian species. The nucleotide c.2396 in TRPV4 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. -
Skeletal dysplasia Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at